证券之星消息，7月30日保险板块较上一交易日上涨1.21%，新华保险领涨。当日上证指数报收于 3615.72，上涨0.17%。深证成指报收于11203.03，下跌0.77%。保险板块个股涨跌见下表： 以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。 从资金流向上来看，当日保险板块主力资金净流入6.4亿元，游资资金净流出3.67亿元，散户资金净流出 2.72亿元。保险板块个股资金流向见下表： | 代码 | 名称 | 主力净流入 (元) | 主力净占比 游资净流入 (元) | | 游资净占比 散户净流入 (元) | | 散户净占比 | | --- | --- | --- | --- | --- | --- | --- | --- | | 601318 中国平安 | | 7.06亿 | 12.61% | -4.12 Z | -7.35% | -2.94亿 | -5.26% | | 601336 新华保险 | | 1963.12万 | 1.00% | 1828.76万 | 0.93% | -3791.88万 | -1.93% | | 60162 ...

Group 1 - The Hang Seng Index fell by 0.43%, down 109 points, while the Hang Seng Tech Index dropped by 1.57%. The morning trading volume in Hong Kong stocks was HKD 148.2 billion [1] - The Hang Seng Biotechnology Index rose by 1.77%, with notable gains from MicroPort Medical (00853) up 9.7%, MicroPort NeuroScience (02172) up over 8%, and Innovent Biologics (01801) up 4.85% [1] - WuXi AppTec (02359) increased by 2.24%, WuXi Biologics (02126) rose by 6.5%, and WuXi Biologics (02269) saw an increase of over 3% after announcing the construction of a modular biomanufacturing facility in Singapore [1] Group 2 - Mindray Medical-B (02160) surged by 8.8% as the company is expected to acquire and restructure the MicroPort cardiac rhythm management business, enhancing its product pipeline [2] - Insurance stocks continued to rise, with New China Life Insurance (01336) up 4.47% and China Life Insurance (02628) increasing by 1.5% [3] Group 3 - 361 Degrees (01361) rose by 6.5%, with the company showing steady revenue growth, and institutions expect strong revenue growth for the full year [4] - Dreamscape (01119) increased by 3.5% after signing a capitalization agreement with Playrix, bringing in a long-term strategic partner [5] Group 4 - GAC Group-B (01167) surged over 20% as a concerted action party increased its holdings by over 60,000 shares, raising its stake to 25.36% [6] - Semiconductor stocks collectively declined, with Hua Hong Semiconductor (01347) down 5.3%, SMIC (00981) down 3.9%, and ASMPT (00522) down 2.74% [6]

Market Overview - The Hang Seng Index fell by 0.43%, down 109 points, while the Hang Seng Tech Index decreased by 1.57%. The early trading volume in Hong Kong stocks was HKD 148.2 billion [1]. Biotechnology Sector - The Hang Seng Biotechnology Index rose by 1.77%. Notable gainers included MicroPort Medical (00853) up 9.7%, MicroPort NeuroTech (02172) up over 8%, and Innovent Biologics (01801) up 4.85% [1]. - WuXi AppTec (02359) increased by 2.24%, WuXi Biologics (02126) rose by 6.5%, and WuXi Biologics (02269) saw an increase of over 3% following the announcement of the construction of a modular biologics manufacturing facility in Singapore [1]. - Fosun Pharma (02196) gained over 5% after acquiring exclusive rights for the innovative Alzheimer's drug AR1001 [1]. - HeartCare Medical-B (02160) surged by 8.8% as the company is expected to acquire and restructure MicroPort's cardiac management business, enhancing its product pipeline [1]. Insurance Sector - Insurance stocks continued their upward trend, with New China Life Insurance (01336) rising by 4.47% to reach a new high, and China Life Insurance (02628) increasing by 1.5% [2]. Consumer Sector - 361 Degrees (01361) rose by 6.5%, with institutions expecting strong revenue growth for the full year [3]. - Dreamland (01119) increased by 3.5% after signing a capitalization agreement with Playrix, bringing in a strategic shareholder from the upstream development sector [4]. Semiconductor Sector - Gako Technology-B (01167) surged over 20% as a concerted action party increased its stake by over 60,000 shares, raising its total holding to 25.36% [5]. - Semiconductor stocks collectively declined, with Huahong Semiconductor (01347) down 5.3%, SMIC (00981) down 3.9%, and ASMPT (00522) down 2.74%. Nvidia's order for 300,000 H20 chips and Morgan Stanley's comments on the potential impact of the 520 unlock on local industry sentiment contributed to this decline [5].

保险股延续近期涨势，截至发稿，新华保险(01336)涨4.57%，报51.5港元；中国人寿(02628)涨1.97%， 报23.35港元；中国太保(02601)涨1.36%，报33.45港元；中国平安(02318)涨0.89%，报56.9港元。 消息面上，近日，保险行业协会公布，当前普通型人身保险产品预定利率研究值为1.99%。根据当前主 要公司已发布的公告来看，普通型人身险产品预定利率将从2.5%下调至2.0%；分红险的保证利率上限 将从2%调整为1.75%，万能险从1.5%调整至1.0%；平安、国寿、太保等公告8月31日之后将全面切换在 售产品至新定价利率要求。 大摩近期研报指，自2023年下半年以来，监管机构和保险公司已采取一系列措施减轻利差损失风险，预 计这一趋势将持续。8月后，保险公司新资金流入的保证负债成本预计将降至约1.7%，可提高盈利能 力，相对目前长期利率高于1.7%。该行指，保险公司表现强劲的关键驱动因素包括近期利率上调、稳 健的2025年上半年业绩预告，以及有利的市场情绪和资金流向。 ...

消息面上，近日，保险行业协会公布，当前普通型人身保险产品预定利率研究值为1.99%。根据当前主 要公司已发布的公告来看，普通型人身险产品预定利率将从2.5%下调至2.0%；分红险的保证利率上限 将从2%调整为1.75%，万能险从1.5%调整至1.0%；平安、国寿、太保等公告8月31日之后将全面切换在 售产品至新定价利率要求。 智通财经APP获悉，保险股延续近期涨势，截至发稿，新华保险(01336)涨4.57%，报51.5港元；中国人 寿(02628)涨1.97%，报23.35港元；中国太保(02601)涨1.36%，报33.45港元；中国平安(02318)涨0.89%， 报56.9港元。 大摩近期研报指，自2023年下半年以来，监管机构和保险公司已采取一系列措施减轻利差损失风险，预 计这一趋势将持续。8月后，保险公司新资金流入的保证负债成本预计将降至约1.7%，可提高盈利能 力，相对目前长期利率高于1.7%。该行指，保险公司表现强劲的关键驱动因素包括近期利率上调、稳 健的2025年上半年业绩预告，以及有利的市场情绪和资金流向。 ...

Group 1 - The core viewpoint of the article is that 130 Chinese companies made it to the 2025 Fortune Global 500 list, with 7 insurance companies included, and most of them improved their rankings compared to the previous year [1][2][3] Group 2 - The 7 Chinese insurance companies on the list are China Life Insurance Group (ranked 45), Ping An Insurance Group (ranked 47), People's Insurance Group of China (ranked 141), China Pacific Insurance (ranked 251), Taikang Insurance Group (ranked 334), AIA Group (ranked 417), and New China Life Insurance (ranked 498) [2][3] - China Life's revenue for 2024 is approximately $160.28 billion, while Ping An's is about $158.63 billion, People's Insurance's is around $86.48 billion, China Pacific's is about $56.16 billion, Taikang's is approximately $45.46 billion, AIA's is around $37.61 billion, and New China's is about $32.29 billion [2][3] Group 3 - China Life improved its ranking from 59 to 45, Ping An from 53 to 47, People's Insurance rose 17 places to 141, and China Pacific saw the largest increase of 80 places to 251 [3] - Taikang Insurance has been on the list for eight consecutive years, moving up 47 places to 334, AIA improved by 29 places to 417, and New China returned to the list at 498 after being absent the previous year [3] Group 4 - The total revenue of the companies on the Fortune Global 500 list is approximately $41.7 trillion, which is more than one-third of the global GDP, showing a growth of about 1.8% from the previous year [3] - The threshold for inclusion in the list increased from $32.1 billion to $32.2 billion, and the total net profit of the listed companies grew by approximately 0.4% to around $2.98 trillion [3]

Group 1 - The 2025 Fortune Global 500 list includes 130 Chinese companies, with 120 from mainland China, 4 from Hong Kong, and 6 from Taiwan [1] - The total revenue of Chinese companies on the list for 2024 is approximately $10.7 trillion, with State Grid Corporation of China leading at $548.4 billion and China General Technology Group at the bottom with $32.3 billion [1] - JD.com ranks highest among private enterprises with a revenue of $161.055 billion for 2024 [1] Group 2 - Among the 33 cities with Fortune Global 500 companies, Beijing, Shanghai, and Shenzhen are the top three, with Beijing having 46 companies [2] - Shanghai has a total of 12 companies, while Shenzhen has 9, with Ping An Insurance ranking highest in Shenzhen at 47th place with a revenue of $158.627 billion [2] - BYD's ranking improved significantly by 52 places due to its leading position in global electric vehicle sales, marking its first entry into the top 100 [2]

新华保险 中国人保 中国人寿 中国平安 中国太保 新华保险 分时图 日K线 周K线 月K线 65.75 -2.49 -3.65% 3.90% 2.59% 1.30% 0.00% 1.30% 2.59% 3.90% 65.58 66.47 67.35 68.24 69.13 70.01 70.90 09:30 10:30 11:30/13:00 14:00 15:00 0 31万 62万 93万 保险股全线飙涨！ 截至7月28日收盘，A股保险板块（申万二级行业）以3.50%的涨幅领涨市场。具体来看，新华保险 （601336）涨超4%，盘中创历史新高；中国太保（601601）、中国平安（601318）涨逾3%；中国人寿 （601628）、中国人保（601319）涨超2%。 港股方面，保险股也持续走强。其中，友邦保险涨超4%；中国太保、中国平安、中国太平等涨逾3%； 新华保险涨幅一度超过7%，创下新高。涨幅居前的认购证也全部来自保险，中国平安的3只认购证实现 翻倍。 那么，究竟发生了什么？ 预定利率再下调 消息面上，7月25日，中国保险行业协会组织召开人身保险业责任准备金评估利率专家咨询委员会2025 年二季度例会 ...

作为成立于1996年的国有控股上市企业，新华保险始终以金融报国为志、以普惠民生为本，坚定推进"以客户为中心"的战略转型，切实发挥保险业"两 器""三网"作用，探索内涵式、高质量发展之路，在"十四五"期间收获丰硕成果——构建起完善的公司治理结构，依托实力雄厚的股东夯实发展根基；打造 专业的代理人队伍，推出多元化产品服务体系；建立险资特色的资产管理模式，康养服务生态圈实现突破性发展，为客户提供全生命周期的全方位保障服 务，公司综合实力跃上新台阶。与此同时，新华保险积极探索"体育赛事""国之重器"等领域的跨界融合、整合传播，持续沉淀品牌价值、激发品牌活力， 使"保得长久、保得美好"的品牌承诺更加深入人心。 2025年上半年，新华保险延续稳健发展态势，累计实现原保险保费收入1212.6亿元，同比增长23%；完成各类理赔金赔付241万件，累计赔付金额73亿元， 日均赔付1.34万件。公司蝉联Forbes全球上市公司2000强、Brand Finance全球最具价值保险品牌、Fitch Ratings财务实力评级A级、WBL中国500最具价值品 牌等多项荣誉，彰显新华保险在经营管理、品牌价值、可持续发展等方面的综合实力。 ...

近日，新华保险发布保费收入公告，2025年上半年，累计原保险保费收入1212.6亿元，同比增长23%。 这家总资产规模近两万亿元的保险企业，在2024年实现业绩高增长后，为2025年迎来 "强势开局" 提供 了最新注解。 保费强劲增长是产品、队伍等多重因素共同作用的结果。规模增长的背后，关乎业务品质和价值的产品 转型也在加力推进。新华保险已经锚定分红险转型，推出多款主力产品。 业内人士表示，分红险具有穿越经济周期的特性，能降低险企利差损压力，亦可满足消费者弹性收益需 求。分红险市场的竞争，更像是一场综合实力的比拼，投资能力、偿付能力、服务能力、股东实力等， 均是重要考察因素。 作为金融国企，新华保险通过专业化、市场化、体系化改革，投资能力进一步凸显，综合实力跃上新台 阶，为下一步分红险转型打下坚实基础。 近期，新华保险正式开启"新华红运季"，推出三大当家分红险产品——盛世荣耀智赢版终身寿险（分红 型）、盛世安盈养老年金保险（分红型）、新华尊悦终身年金保险（分红型）。 新华保险管理层介绍，产品竞争力的打造和组织队伍的优增，是近两年改革的重要方向，2025年将重点 推动分红险转型，并规划一系列组合拳，改善未来业务 ...